Tecan, a global provider of laboratory automation and life sciences solutions listed on the SIX Swiss Exchange, has announced the launch of its direct operations in India with the establishment of a dedicated local sales and specialist service team based in Gurugram, near New Delhi. The launch marks a significant milestone in Tecan’s global expansion strategy and reinforces the company’s commitment to supporting customers in one of the fastest-growing life sciences markets worldwide. The announcement was formally marked through a ribbon-cutting ceremony attended by company representatives and industry stakeholders.
For more than a decade, Tecan has served customers in India through its long-standing distributor partner, Bioscreen. With the formation of Tecan India, the company will continue collaborating closely with Bioscreen while expanding direct engagement with customers across the pharmaceutical, biotechnology, diagnostics, and academic research sectors.
According to the company, the new India operations will enable stronger local collaboration, faster customer support, and improved access to Tecan’s laboratory automation technologies and services. The company believes the move will strengthen its ability to address the growing demand for advanced automation and precision laboratory solutions in India’s expanding healthcare and life sciences ecosystem. Tecan India was officially incorporated on April 1, 2026, and will serve as a regional hub for sales, technical support, and customer service operations.
Mukta Acharya, Executive Vice President and Head of Tecan’s Life Sciences business, said India represents a strategically important market for the company’s long-term growth plans. “India continues to witness strong momentum across contract research organizations, pharmaceuticals, biotechnology, and diagnostics. Establishing a direct presence allows us to work more closely with customers, deepen partnerships, and strengthen the support and value we deliver locally,” she said.
The India expansion follows Tecan’s broader efforts to strengthen its presence in high-growth international markets. In 2024, the company expanded operations into South Korea, reflecting its ongoing strategy to build stronger customer engagement capabilities across key life sciences regions.
Tecan stated that its broader mission is focused on improving health outcomes by enabling healthcare and scientific innovation through advanced laboratory technologies and automation systems. The company provides automation platforms, instruments, and software solutions that support research, diagnostics, drug discovery, and clinical workflows globally.
Industry analysts note that India’s life sciences and healthcare sectors are experiencing rapid growth driven by increasing pharmaceutical manufacturing, biotechnology investments, clinical research activity, and expansion in diagnostic infrastructure. This trend is creating rising demand for laboratory automation solutions capable of improving efficiency, accuracy, and scalability in research and healthcare environments. Through its expanded local operations, Tecan aims to strengthen customer relationships, accelerate service delivery, and support the evolving requirements of India’s life sciences ecosystem with advanced automation technologies and localized technical expertise.
